Rate My Professor Shazleen Azman

Dr. Adzzie Shazleen Azman is a Lecturer in Microbiology in the School of Science at Monash University Malaysia. Her academic background includes a Bachelor of Science in Biotechnology (Honours) from Monash University Malaysia obtained in 2011, followed by a Doctor of Philosophy in Microbiology from the same university in 2016. Her PhD research centered on the discovery and characterization of novel rare Actinobacteria from mangrove ecosystems, culminating in the identification of Monashia flava gen. nov., sp. nov., a new bacterial genus named in honor of her alma mater, as well as two new species of rare Actinobacteria. After her doctorate, she worked as a Postdoctoral Research Fellow at Universiti Malaya from February 2017 to February 2020. She joined Monash University Malaysia in August 2020 as a Lecturer in Microbiology, where she contributes to teaching, including the unit Fundamentals of Microbiology, and supervises undergraduate and postgraduate research projects.

Dr. Azman's research specializations lie in microbiology, bacteriology, infectious diseases, Actinobacteria, and antimicrobial agents, with a focus on the bioactivities of secondary metabolites from Actinobacteria and their potential therapeutic applications against viral infections and multidrug-resistant bacteria. Her career history features significant contributions to fields such as antiviral compounds, biofilm inhibitors, and microbial diversity. Key publications include "Microbial pigments and therapeutic potential: Current status and opportunities" (2026), "Effect of secondary metabolites from Streptomyces sp. KSF103 on dengue virus 2 replication competency in C6/36 cells and identification of potent dengue virus 2 inhibitors" (2025), "Hidden risks of biofilm-forming and multidrug-resistant Gram-negative bacteria in water vending machines" (2025), "Microbiota–Host Interactions: Exploring Their Dynamics and Contributions to Human Diseases" (2025), "Unlocking nature's hidden treasures: Actinomycetota's arsenal of potent antiviral compounds against human viral infections" (2025), "Streptomyces pluripotens sp. nov., a bacteriocin-producing streptomycete inhibiting methicillin-resistant Staphylococcus aureus" (2014), and "Mangrove rare actinobacteria: taxonomy, natural compound, and discovery of bioactivity" (2015). She was awarded the Singapore Academies Southeast Asia Fellowship in December 2024, supporting her ongoing research on antiviral activities of compounds from novel Actinomycetes strains at the National University of Singapore until December 2026; she is the first academic from Monash University Malaysia to receive this honor. Dr. Azman serves as a member of the programme committee for the International Congress of the Malaysian Society for Microbiology 2025 and welcomes collaborations.